Medicare Enrolled

Dr. Emanuel Gottenger, M.D.

Urology Physician · Delray Beach, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
5350 W. ATLANTICE AVENUE, Delray Beach, FL 33484
5614964444
In practice since 2006 (19 years)
NPI: 1043261548 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gottenger from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gottenger? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gottenger

Dr. Emanuel Gottenger is an urology physician in Delray Beach, FL, with 19 years in practice. Based on federal Medicare data, Dr. Gottenger performed 11,638 Medicare services across 5,650 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gottenger received a total of $13,816 from 62 pharmaceutical and/or device companies across 461 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gottenger is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 10% volume in FL$ $13,816 industry payments

Medicare Practice Summary

Medicare Utilization ↗
11,638
Medicare services
Top 10% in FL for urology physician
5,650
Unique beneficiaries
$38
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~613 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
BCG treatment for bladder cancer2,800$2$4
Automated urinalysis1,984$2$17
Office visit, established patient (30-39 min)1,617$98$175
Office visit, established patient (20-29 min)1,036$71$125
Bladder ultrasound after voiding975$8$100
Urinalysis with microscopic exam626$3$17
New patient office visit (45-59 min)344$126$240
Blood draw (venipuncture)285$8$11
PSA test (prostate cancer screening)271$18$68
Diagnostic exam of bladder and urethra using an endoscope186$189$500
Leuprolide acetate (for depot suspension), 7.5 mg162$138$800
Hospital follow-up visit, high complexity134$100$200
Limited ultrasound scan of pelvis97$39$150
Limited ultrasound scan behind abdominal cavity96$47$200
Insertion of temporary bladder tube88$37$175
Electronic assessment of bladder emptying86$8$225
Simple change of bladder tube83$77$250
Simple insertion of temporary bladder tube82$49$200
Insertion of lower leg neurostimulator electrode70$93$248
Drug injection, under skin or into muscle69$11$35
Ceftriaxone antibiotic injection60$0$25
Instillation of anti-cancer drug into bladder56$71$425
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle54$27$80
Initial hospital admission, high complexity54$143$300
Psa (prostate specific antigen) measurement, free45$18$68
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional41$19$80
Testosterone (hormone) level, total35$25$60
Injection, garamycin, gentamicin, up to 80 mg27$2$25
Simple bladder irrigation and/or instillation23$62$300
Biopsy of prostate gland19$108$400
Ultrasonic guidance for needle placement19$25$300
Complex measurement of pressure of urine flow in bladder with voiding pressure studies16$291$450
Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings16$27$325
Insertion of device into abdomen with pressure and urine flow rate study16$159$500
Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope16$267$800
Insertion of stent in ureter using an endoscope15$75$1,600
Dilation of urethra using an endoscope12$260$1,000
Ultrasound scan of pelvic region through rectum12$112$245
Crushing of stone of ureter with insertion of stent using an endoscope11$346$1,125
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.4% high complexity
12.1% medium
87.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$13,816
Total received (2018-2024)
Avg $1,974/year across 7 years
Top 16% in FL for urology physician
62
Companies
461
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,632 (98.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$184 (1.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,239
2023
$1,602
2022
$3,096
2021
$2,653
2020
$912
2019
$1,922
2018
$2,392

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$2,056
PROCEPT BioRobotics Corporation
$1,554
Axonics, Inc.
$1,143
NeoTract Inc.
$652
PFIZER INC.
$629
Endo Pharmaceuticals Inc.
$628
Dendreon Pharmaceuticals LLC
$612
Boston Scientific Corporation
$482
TOLMAR Pharmaceuticals, Inc.
$450
Janssen Biotech, Inc.
$448
Blue Earth Diagnostics Limited
$421
BOSTON SCIENTIFIC CORPORATION
$397
Olympus America Inc.
$305
AbbVie, Inc.
$286
Amgen Inc.
$239
ABBVIE INC.
$206
Sumitomo Pharma America, Inc.
$205
Laborie Medical Technologies Corp.
$204
AstraZeneca Pharmaceuticals LP
$193
UroGen Pharma, Inc.
$188
COLOPLAST CORP
$177
Augmenix, Inc.
$157
Terumo Medical Corporation
$142
Janssen Scientific Affairs, LLC
$141
AbbVie Inc.
$132
Antares Pharma, Inc.
$131
Tolmar, Inc.
$121
Avadel Specialty Pharmaceuticals, LLC
$114
Davol Inc.
$104
MEDIVATION FIELD SOLUTIONS LLC
$102
Coloplast Corp
$99
ROCHESTER MEDICAL CORPORATION
$98
C. R. BARD, INC. & SUBSIDIARIES
$97
C. R. Bard, Inc. & Subsidiaries
$75
Bayer HealthCare Pharmaceuticals Inc.
$74
ConvaTec Inc.
$66
Becton, Dickinson and Company
$58
Endo USA, Inc.
$45
ACCORD HEALTHCARE, INC.
$44
Supernus Pharmaceuticals, Inc.
$40
Myriad Genetic Laboratories, Inc.
$37
Medtronic, Inc.
$37
Aytu BioScience, Inc
$35
Ambu Inc.
$33
PROGENICS PHARMACEUTICALS, INC.
$26
180 Medical, Inc.
$25
Metuchen Pharmaceuticals
$25
Myovant Sciences Inc.
$24
Agiliti Surgical, Inc.
$24
Janssen Pharmaceuticals, Inc
$24
Ferring Pharmaceuticals Inc.
$23
Clarus Therapeutics Inc.
$23
Novartis Pharmaceuticals Corporation
$23
UROVANT SCIENCES INC
$20
Acerus Pharmaceuticals Corporation
$19
Teleflex LLC
$18
UROGEN PHARMA, INC.
$17
Allergan, Inc.
$15
Accord Healthcare, Inc.
$15
Allergan Inc.
$14
Mission Pharmacal Company
$13
Medtronic USA, Inc.
$13
Top 3 companies account for 34.4% of total payments
Associated products mentioned in payments ›
ADSTILADRIN · AMS 700 · AMS 700 CXR RTE KIT · AMS 700 CXR RTE Kit · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · ARISTA AH FLEXITIP · AVEED · Androgel · Axonics · Axonics r-SNM System · Axumin · BOTOX · BOTOX THERAPEUTIC · Bard InLay Optima Ureteral Stent with HydroGlide Guidewire · Bard Urinary Drainage Bag · Bulkamid · CAMCEVI · EDEX · ELIGARD · ERLEADA · EndoSheath Technology · Erleada · GEMTESA · GENERAL BPH · GENERAL THERAPIES · GENTLECATH · GLIDESHEATH SLENDER · GREENLIGHT · GentleCath · INTERSTIM · JATENZO · JELMYTO · LITHOVUE · LUPRON DEPOT · LYNPARZA · LithoVue · Luja Coude · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · Olympus Cysto-Resection · Optilume BPH Drug Coated Balloon Catheter · Otrexup · PLUVICTO · POSLUMA · PROVENGE · PYLARIFY · Prolaris · Prolia · REZUM · Rezum Generator · SPEEDICATH · SUTENT · SpaceOAR · SpaceOAR VUE System - 10mL · SpeediCath · Stendra · TITAN · TOVIAZ · UGN Laser Capital · UROLIFT · UroLift · Urocit-K · XARELTO · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · ZYTIGA · iTIND System · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $119 per 100 Medicare services performed
Looking for a urology physician in Delray Beach?
Compare urology physicians in the Delray Beach area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology Physicians within 10 mi
101
Per 100K population
6.7
County median income
$81,115
Nearest hospital
DELRAY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Gottenger is a clinical cardiology specialist, with above-average Medicare volume (top 10% in FL), and high industry engagement (low-engagement, top 16%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Gottenger experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Gottenger performed 2,800 bcg treatment for bladder cancer services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gottenger receive payments from pharmaceutical companies?
Yes. Dr. Gottenger received a total of $13,816 from 62 companies across 461 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gottenger's costs compare to other urology physicians in Delray Beach?
Dr. Gottenger's average Medicare payment per service is $38. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gottenger) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →